Detalhe da pesquisa
1.
Comparison of the immunogenicity of nasal-spray rVSV vector, adenovirus vector, and inactivated COVID-19-based vaccines in rodent models.
J Med Virol
; 95(5): e28806, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37219050
2.
CpG 684: an effective adjuvant for the inactivated COVID-19 vaccine in mice.
Future Virol
; 18(7): 403-410, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38051998